Guoxiang X. Cai

2Department Of Oncology, 270 Dong'an Road
Shanghai, 200032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 133 publications

Translational research advances in peritoneal metastasis of gastrointestinal cancer: from molecular mechanisms to precision therapy

Translational research advances in peritoneal metastasis of gastrointestinal cancer: from molecular mechanisms to precision therapy

Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery

Published: April 27, 2026

PTPRN2-mediated silencing of tumor-intrinsic MHC-II promotes immune-excluded tumor microenvironment in colorectal cancer.

PTPRN2-mediated silencing of tumor-intrinsic MHC-II promotes immune-excluded tumor microenvironment in colorectal cancer.

Journal: Cancer genetics

Published: March 27, 2026

PDK4-driven metabolic reprogramming enhances mesothelial cell invasion in colorectal cancer peritoneal metastasis.

PDK4-driven metabolic reprogramming enhances mesothelial cell invasion in colorectal cancer peritoneal metastasis.

Journal: Acta biochimica et biophysica Sinica

Published: January 29, 2026

Correction: Han et al. Enhanced De Novo Lipid Synthesis Mediated by FASN Induces Chemoresistance in Colorectal Cancer. Cancers 2023, 15, 562.

Correction: Han et al. Enhanced De Novo Lipid Synthesis Mediated by FASN Induces Chemoresistance in Colorectal Cancer. Cancers 2023, 15, 562.

Journal: Cancers

Published: November 25, 2025

An exosome-based liquid biopsy to predict molecular residual disease for the identification of high-risk patients with stage II-III colorectal cancer: the CLEAR study.

An exosome-based liquid biopsy to predict molecular residual disease for the identification of high-risk patients with stage II-III colorectal cancer: the CLEAR study.

Journal: Molecular cancer

Published: November 05, 2025

Cancer-associated adipocytes promote peritoneal metastasis of colorectal signet ring cell carcinoma via FABP4 induction.

Cancer-associated adipocytes promote peritoneal metastasis of colorectal signet ring cell carcinoma via FABP4 induction.

Journal: Cell communication and signaling : CCS

Published: June 22, 2025

Corrigendum to "High expression of PAX8-AS1 correlates with poor prognosis and response to fluorouracil-based chemotherapy in stage II colon cancer" [Translational oncology vol. 50 (2024): 102128].

Corrigendum to "High expression of PAX8-AS1 correlates with poor prognosis and response to fluorouracil-based chemotherapy in stage II colon cancer" [Translational oncology vol. 50 (2024): 102128].

Journal: Translational oncology

Published: June 16, 2025

SPAG5 promotes ferroptosis and enhances chemotherapy efficacy in locally advanced colorectal cancer via upregulating intracellular ROS levels.

SPAG5 promotes ferroptosis and enhances chemotherapy efficacy in locally advanced colorectal cancer via upregulating intracellular ROS levels.

Journal: Apoptosis : an international journal on programmed cell death

Published: March 24, 2025

Correction: myCAF-derived Exosomal PWAR6 accelerates CRC liver metastasis via altering glutamine availability and NK cell function in the tumor microenvironment.

Correction: myCAF-derived Exosomal PWAR6 accelerates CRC liver metastasis via altering glutamine availability and NK cell function in the tumor microenvironment.

Journal: Journal of hematology & oncology

Published: March 19, 2025

Retraction Note: MALAT1 regulates the transcriptional and translational levels of proto-oncogene RUNX2 in colorectal cancer metastasis.

Retraction Note: MALAT1 regulates the transcriptional and translational levels of proto-oncogene RUNX2 in colorectal cancer metastasis.

Journal: Cell death & disease

Published: March 05, 2025

TRAF4 promotes lung cancer development by activating tyrosine kinase of EGFR

TRAF4 promotes lung cancer development by activating tyrosine kinase of EGFR

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: October 16, 2024

myCAF-derived exosomal PWAR6 accelerates CRC liver metastasis via altering glutamine availability and NK cell function in the tumor microenvironment.

myCAF-derived exosomal PWAR6 accelerates CRC liver metastasis via altering glutamine availability and NK cell function in the tumor microenvironment.

Journal: Journal of hematology & oncology

Published: September 10, 2024

Showing 1-12 of 133

Last Updated: 09/26/2026